Difference between revisions of "Fluphenazine LA-Aripiprazole"

From Psychiatrienet
Jump to: navigation, search
(Created page with '{{Drugswitch | from = Fluphenazine_LA | to = Aripiprazole | stop = {{Lastinjection}} | start = {{Start}} | info = {{caveQT}} | view = empty.jpg }}')
 
 
Line 5: Line 5:
 
| start = {{Start}}
 
| start = {{Start}}
 
| info = {{caveQT}}
 
| info = {{caveQT}}
| view = empty.jpg
+
| view = StopDepotStartArip.jpg
 
}}
 
}}

Latest revision as of 16:25, 26 August 2009

Fluphenazine
long acting
Type Antipsychotic
Group Phenothiazines
links
Medscape Fluphenazine
PubChem 3372
PubMed Fluphenazine
Kompas (Dutch) Fluphenazine
Wikipedia Fluphenazine
Aripiprazole
Type Antipsychotic
Group Atypical AP
Other use moodstabilizer
links
Medscape Aripiprazole
EMEA abilify
PubChem 60975
PubMed Aripiprazole
Kompas (Dutch) Aripiprazole
Wikipedia Aripiprazole

Switch medication from Fluphenazine_LA to Aripiprazole.

Nietinrijdenbord.png Stop Fluphenazine_LA
  • Day 1: Last depot injection
Eenrichtingbord.png Start Aripiprazole
  • Day 1: Start drug at target dose
Infobord.png More information
  • During this switch you could monitor ECG, especially in patients prone to QT-conduction problems.
  • There is a possibility of QT interval prolongation.[1]
    StopDepotStartArip.jpg
Nietinrijdenbord.png — Fluphenazine_LA
Eenrichtingbord.png — Aripiprazole


  1. Stöllberger C, Huber JO, Finsterer J, Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol. 2005 Sep;20(5):243-51.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.